Your browser doesn't support javascript.
loading
Development of Rapid Advice Guidelines for the Treatment of Coronavirus Disease 2019 with Traditional Chinese Medicine.
Liang, Ning; Li, Huizhen; Wang, Jingya; Jiao, Liwen; Ma, Yanfang; Wang, Xiaohui; Liu, Bin; Luo, Xufei; Zhao, Siya; Lv, Meng; Cao, Jin; Hu, Wenpin; Zhang, Hairong; Xiong, Yibai; Tian, Yaxin; Chen, Yaolong; Wang, Yanping; Shi, Nannan.
Afiliación
  • Liang N; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China.
  • Li H; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China.
  • Wang J; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China.
  • Jiao L; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China.
  • Ma Y; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China.
  • Wang X; School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China.
  • Liu B; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China.
  • Luo X; School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China.
  • Zhao S; School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China.
  • Lv M; School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China.
  • Cao J; School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China.
  • Hu W; School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China.
  • Zhang H; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China.
  • Xiong Y; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China.
  • Tian Y; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, P. R. China.
  • Chen Y; Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China.
  • Wang Y; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou University, Lanzhou 730000, P. R. China.
  • Shi N; Chinese GRADE Center, Lanzhou 730000, P. R. China.
Am J Chin Med ; 48(7): 1511-1521, 2020.
Article en En | MEDLINE | ID: mdl-33148006
ABSTRACT
The worldwide spread of the 2019 novel coronavirus has become a profound threat to human health. As the use of medication without established effectiveness may result in adverse health consequences, the development of evidence-based guidelines is of critical importance for the clinical management of coronavirus disease (COVID-19). This research presents methods used to develop rapid advice guidelines on treating COVID-19 with traditional Chinese medicine (TCM). We have followed the basic approach for developing WHO rapid guidelines, including preparing, developing, disseminating and updating each process. Compared with general guidelines, this rapid advice guideline is unique in formulating the body of evidence, as the available evidence for the treatment of COVID-19 with TCM is from either indirect or observational studies, clinical first-hand data together with expert experience in patients with COVID-19. Therefore, our search of evidence not only focuses on clinical studies of treating COVID-19 with TCM but also of similar diseases, such as pneumonia and influenza. Grading of recommendations assessment, development and evaluation (GRADE) methodology was adopted to rate the quality of evidence and distinguish the strength of recommendations. The overall certainty of the evidence is graded as either high, moderate, low or very low, and to give either "strong" or "weak" recommendations of each TCM therapy. The output of this paper will produce the guideline on TCM for COVID-19 and will also provide some ideas for evidence collection and synthesis in the future development of rapid guidelines for COVID-19 in TCM as well as other areas.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Medicamentos Herbarios Chinos / Guías de Práctica Clínica como Asunto / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Medicina Tradicional China Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies Idioma: En Revista: Am J Chin Med Año: 2020 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Medicinas Tradicionales: Medicinas_tradicionales_de_asia / Medicina_china Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas Asunto principal: Medicamentos Herbarios Chinos / Guías de Práctica Clínica como Asunto / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Medicina Tradicional China Tipo de estudio: Diagnostic_studies / Guideline / Observational_studies Idioma: En Revista: Am J Chin Med Año: 2020 Tipo del documento: Article